Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
HCP confirmed that patient did not have any symptomatic events; HCP reported that a patient who initially was looking to receive SHINGRIX was accidently administered VARIVAX; This spontaneous report was received from a Register Nurse and refers to a 52-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-MAY-2025, the patient was accidentally vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #, dose, strength, route of administration and anatomical location of vaccine and expiration date were not reported) diluted with sterile diluent (MERCK STERILE DILUENT); instead of a dose of Varicella zoster vaccine rgE (CHO) (SHINGRIX) (Wrong vaccine administered) for prophylaxis. It was confirmed that the patient did not have any symptomatic events. Lot # is being requested and will be submitted if reported.
Sterile diluent